Andrew D. Goldberg - Net Worth and Insider Trading
Andrew D. Goldberg Net Worth
The estimated net worth of Andrew D. Goldberg is at least $142,770 dollars as of 2024-11-13. Andrew D. Goldberg is the Director of Tarsus Pharmaceuticals Inc and owns about 3,000 shares of Tarsus Pharmaceuticals Inc (TARS) stock worth over $142,770. Details can be seen in Andrew D. Goldberg's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Andrew D. Goldberg has not made any transactions after 2023-12-15 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Andrew D. Goldberg
Andrew D. Goldberg Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Andrew D. Goldberg owns 1 companies in total, including Tarsus Pharmaceuticals Inc (TARS) .
Click here to see the complete history of Andrew D. Goldberg’s form 4 insider trades.
Insider Ownership Summary of Andrew D. Goldberg
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| TARS | Tarsus Pharmaceuticals Inc | 2023-12-15 | director |
Andrew D. Goldberg Latest Holdings Summary
Andrew D. Goldberg currently owns a total of 1 stock. Andrew D. Goldberg owns 3,000 shares of Tarsus Pharmaceuticals Inc (TARS) as of December 15, 2023, with a value of $142,770.
Latest Holdings of Andrew D. Goldberg
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| TARS | Tarsus Pharmaceuticals Inc | 2023-12-15 | 3,000 | 47.59 | 142,770 |
Holding Weightings of Andrew D. Goldberg
Andrew D. Goldberg Form 4 Trading Tracker
According to the SEC Form 4 filings, Andrew D. Goldberg has made a total of 1 transactions in Tarsus Pharmaceuticals Inc (TARS) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Tarsus Pharmaceuticals Inc is the acquisition of 1,000 shares on December 15, 2023, which cost Andrew D. Goldberg around $18,960.
Insider Trading History of Andrew D. Goldberg
- 1
Andrew D. Goldberg Trading Performance
GuruFocus tracks the stock performance after each of Andrew D. Goldberg's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Andrew D. Goldberg is 65.77%. GuruFocus also compares Andrew D. Goldberg's trading performance to market benchmark return within the same time period. The performance of stocks bought by Andrew D. Goldberg within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Andrew D. Goldberg's insider trading performs compared to the benchmark.
Performance of Andrew D. Goldberg
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 16.01 |  | | | | |
| Relative Return to S&P 500(%) | 14.64 | | | | | |
Andrew D. Goldberg Ownership Network
Ownership Network List of Andrew D. Goldberg
Ownership Network Relation of Andrew D. Goldberg
Andrew D. Goldberg Owned Company Details
What does Tarsus Pharmaceuticals Inc do?
Who are the key executives at Tarsus Pharmaceuticals Inc?
Andrew D. Goldberg is the director of Tarsus Pharmaceuticals Inc. Other key executives at Tarsus Pharmaceuticals Inc include See Remarks Jeffrey S Farrow , Chief Human Resources Officer Dianne C. Whitfield , and director & 10 percent owner & President and CEO Bobak R. Azamian .
Tarsus Pharmaceuticals Inc (TARS) Insider Trades Summary
Over the past 18 months, Andrew D. Goldberg made 1 insider transaction in Tarsus Pharmaceuticals Inc (TARS) with a net purchase of 1,000. Other recent insider transactions involving Tarsus Pharmaceuticals Inc (TARS) include a net sale of 231,415 shares made by Bobak R. Azamian , a net sale of 11,909 shares made by Aziz Mottiwala , and a net sale of 12,792 shares made by Bryan Wahl .
In summary, during the past 3 months, insiders sold 0 shares of Tarsus Pharmaceuticals Inc (TARS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 322,965 shares of Tarsus Pharmaceuticals Inc (TARS) were sold and 10,506 shares were bought by its insiders, resulting in a net sale of 312,459 shares.
Tarsus Pharmaceuticals Inc (TARS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Tarsus Pharmaceuticals Inc Insider Transactions
Andrew D. Goldberg Mailing Address
Above is the net worth, insider trading, and ownership report for Andrew D. Goldberg. You might contact Andrew D. Goldberg via mailing address: 15440 Laguna Canyon Road, Suite 160, Irvine Ca 92618.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
